 We are pleased to announce that under the leadership of the Editor-in-Chief and with the support of the entire editorial staff, Trends in Immunotherapy has been accepted by Scopus. Content Selection & Advisory Board (CSAB) fully affirmed and spoke highly of it. Since its establishment in 2017, each article in the journal has undergone strict peer review and other relevant evaluations, which ensures the professionalism and quality of the journal. Preliminary studies, pre-clinical and clinical investigative reports are welcomed. |
This site is licensed under a Creative Commons Attribution 4.0 International License.